The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 05, 2010

Filed:

Apr. 10, 2007
Applicants:

Tao Wang, Farmington, CT (US);

John F. Kadow, Wallingford, CT (US);

Zhongxing Zhang, Madison, CT (US);

Zhiwei Yin, Glastonbury, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Alicia Regueiro-ren, Middletown, CT (US);

Jacob Swidorski, Southington, CT (US);

Ying Han, Cheshire, CT (US);

David J. Carini, Wallingford, CT (US);

Inventors:

Tao Wang, Farmington, CT (US);

John F. Kadow, Wallingford, CT (US);

Zhongxing Zhang, Madison, CT (US);

Zhiwei Yin, Glastonbury, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Alicia Regueiro-Ren, Middletown, CT (US);

Jacob Swidorski, Southington, CT (US);

Ying Han, Cheshire, CT (US);

David J. Carini, Wallingford, CT (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/437 (2006.01); C07D 471/04 (2006.01); A61K 31/4436 (2006.01); A61K 31/4427 (2006.01); A61K 31/18 (2006.01); C07D 403/12 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with diketo piperazine and piperadine derivatives that possess unique antiviral activity useful for the treatment of HIV and AIDS. More particularly, the present disclosure relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, wherein:


Find Patent Forward Citations

Loading…